ONE CARMEL LAUNCHES RESIDENTIAL SALES, INTRODUCING A NEW STANDARD FOR COASTAL LIVING IN CARMEL VALLEY
Press Release

ONE CARMEL LAUNCHES RESIDENTIAL SALES, INTRODUCING A NEW STANDARD FOR COASTAL LIVING IN CARMEL VALLEY

Exclusive Residential Enclave Debuts Plans for 73 Magnificent Estate Parcels and Built Homes Anchored by Historic Equestrian Facilities, Wellness Amenities and Advanced Technology Infrastructure CARMEL VALLEY, Calif., July 13, 2026 /PRNewswire/ — ONE Carmel, a private residential community spanning 891 acres in Carmel Valley, California, announces the launch of sales for 73 expansive homesites and built […]

Read More
Tomocube Launches HT-T1 Desktop for 3D Glass Substrate Defect Analysis in Advanced Packaging
Press Release

Tomocube Launches HT-T1 Desktop for 3D Glass Substrate Defect Analysis in Advanced Packaging

Provides non-destructive 3D analysis of the location, morphology, and depth profile of internal defects in glass substrates Introduces TAMI, a dedicated 3D analysis software platform that connects R&D analysis with production-line review Accelerates root-cause analysis and yield learning for glass substrates, a key material for next-generation advanced packaging DAEJEON, South Korea, July 13, 2026 /PRNewswire/ […]

Read More
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.77 Million Tokens, and Total Crypto and Total Cash Holdings of .3 Billion
Press Release

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.77 Million Tokens, and Total Crypto and Total Cash Holdings of $11.3 Billion

Bitmine owns 4.8% of the total ETH coin supply of 120.7 million Bitmine is 96% of the way to the ‘Alchemy of 5%’ in just 12 months Bitmine was added to the Russell 1000 Large-cap index on June 26, 2026 Bitmine’s Series A Preferred Stock is trading on the NYSE under the symbol BMNP Bitmine […]

Read More
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
Press Release

Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business

Acquisition supports Servier’s strategic ambition in rare neurology with sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies.   The acquired asset and expert team strengthen Servier’s commitment to innovate for patients with high unmet medical needs.   SURESNES, France, July 13, 2026 /PRNewswire/ — Servier, an independent international pharmaceutical group governed by a foundation, today announced that it has completed the acquisition of the muscular dystrophy business of Edgewise Therapeutics Inc. (Nasdaq: EWTX), for up to $2.65 billion, including […]

Read More
BUSINESSES CONTINUE BUILDING BUFFER STOCKS IN ANTICIPATION OF FURTHER DISRUPTION AS SUPPLY SHORTAGES PERSIST: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
Press Release

BUSINESSES CONTINUE BUILDING BUFFER STOCKS IN ANTICIPATION OF FURTHER DISRUPTION AS SUPPLY SHORTAGES PERSIST: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Manufacturers’ reports of supply shortages among their highest since late 2022, signaling supply-chain bottlenecks will continue into at least the third quarter Businesses continued building buffer inventories, driving another month of strong demand for raw materials, commodities and intermediate goods Demand stayed strong in North America and Asia, but European manufacturers retrenched in June CLARK, […]

Read More
Delonix Bioworks Announces First Participant Dosed in Phase 1 Clinical Trial of Next-Generation MenB OMV Vaccine DX-104 in China
Press Release

Delonix Bioworks Announces First Participant Dosed in Phase 1 Clinical Trial of Next-Generation MenB OMV Vaccine DX-104 in China

SHANGHAI, July 13, 2026 /PRNewswire/ — Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced that the first participant has been dosed in its Phase 1 clinical trial of DX-104 in China. DX-104 is an innovative Group B meningococcal (MenB) vaccine candidate developed using the company’s proprietary OMV Plus® platform. This […]

Read More
POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement
Press Release

POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement

GUANGZHOU, China, July 13, 2026 /PRNewswire/ — POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today announced that on July 10, 2026, the Company received a letter (the "Compliance Letter") from The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it […]

Read More
From the Lab to the Road: How Training Science Arrives in Brazil with the HUAWEI WATCH GT Runner 2
Press Release

From the Lab to the Road: How Training Science Arrives in Brazil with the HUAWEI WATCH GT Runner 2

Two-time Olympic champion runs in Brazil with the smartwatch he helped create BRASILIA, Brazil, July 13, 2026 /PRNewswire/ — For decades, elite racing relied on highly precise positioning and professional full-marathon modes — advantages strictly reserved for professional teams. To nail accurate pace tracking and stable full-race monitoring, runners once depended on sophisticated professional gear […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.